-
Product Insights
Iso Pihlajasuo Wind Power Project
Iso Pihlajasuo Wind Power Project is an Onshore Wind project located in Northern Ostrobothnia, Finland. The project is at the permitting stage. Empower your strategies with our Iso Pihlajasuo Wind Power Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based...
-
Product Insights
Iso-Petajamaki Wind Farm
Iso-Petajamaki Wind Farm is an Onshore Wind project located in Northern Savonia, Finland. The project is owned and being developed by ABO Wind Oy. The project is at the permitting stage. Empower your strategies with our Iso-Petajamaki Wind Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the...
-
Product Insights
Iso Rytisuo Wind Power Project
Iso Rytisuo Wind Power Project is an Onshore Wind project located in Northern Ostrobothnia, Finland. The project is owned and being developed by Infinergies Finland Oy. The project is at the permitting stage. Empower your strategies with our Iso Rytisuo Wind Power Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays....
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Aflibercept in Graves’ Ophthalmopathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Aflibercept in Graves' Ophthalmopathy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Aflibercept in Graves' Ophthalmopathy Drug Details: Aflibercept (Eylea / Eylea HD) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Aflibercept in Retinopathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Aflibercept in Retinopathy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Aflibercept in Retinopathy Drug Details: Aflibercept (Eylea / Eylea HD) is a recombinant...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Aflibercept in Optic Neuropathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Aflibercept in Optic Neuropathy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Aflibercept in Optic Neuropathy Drug Details: Aflibercept (Eylea / Eylea HD) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KOS-1803 in Solid Tumor
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. KOS-1803 in Solid Tumor Drug Details: KOS-1803 (Iso-Fludelone) is under development for the treatment of...
-
Company Insights
Under Armour, Inc. – Digital Transformation Strategies
Under Armour Digital Transformation Strategies Overview Under Armour, Inc. (Under Armour) is leveraging several emerging technologies, including AI, cloud, augmented reality, 3D printing, and metaverse among others to improve business operations, enhance customer service and develop better products. The annual ICT spending of Under Armour was estimated at $70.1 million for 2023. A major share of this spending is earmarked for acquiring software, ICT services and network and communications from vendors. Under Armour develops, markets, and distributes branded performance footwear,...
-
Product Insights
Barishal Coal Fired Power Project
Barishal Coal Fired Power Project is a thermal project located in Barisal, Bangladesh. The project is owned and developed by ISO Tech Electrification Co Ltd; Powerchina Resources Ltd; Taylor Power Environmental Ltd. The project is currently partially active. Empower your strategies with our Barishal Coal Fired Power Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Aflibercept in Age Related Macular Degeneration
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Aflibercept in Age Related Macular Degeneration report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Aflibercept in Age Related Macular Degeneration Drug Details: Aflibercept (Eylea...